CONARIS RES INSTITUTE AG has a total of 35 patent applications. It decreased the IP activity by 85.0%. Its first patent ever was published in 2005. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets pharmaceuticals and biotechnology are MEDICE ARZNEIMITTEL PUETTER GMBH & CO KG, HMFRA HUNGARY LTD LIABILITY COMPANY and TANGENT REPROFILING LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 7 | |
#2 | United States | 6 | |
#3 | Australia | 4 | |
#4 | Canada | 4 | |
#5 | Brazil | 2 | |
#6 | Japan | 2 | |
#7 | South Africa | 2 | |
#8 | China | 1 | |
#9 | Hungary | 1 | |
#10 | Israel | 1 | |
#11 | Jordan | 1 | |
#12 | Republic of Korea | 1 | |
#13 | Mexico | 1 | |
#14 | Serbia | 1 | |
#15 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Seegert Dirk | 20 |
#2 | Waetzig Georg | 11 |
#3 | Wätzig Georg | 9 |
#4 | Dirk Seegert | 6 |
#5 | Schwarz Karin | 5 |
#6 | Schreiber Stefan | 5 |
#7 | Theismann Eva-Maria | 5 |
#8 | Keppler Julia | 5 |
#9 | Georg Waetzig | 4 |
#10 | Watzig Georg | 3 |
Publication | Filing date | Title |
---|---|---|
EP3445360A1 | Oral pharmaceutical compositions of nicotinamide | |
EP3079675A2 | A pharmaceutical composition containing nicotinic acid and/or nicotinamide for use in beneficially influencing blood lipid levels by modifying the intestinal microbiota | |
EP3007680A1 | Extended release nicotinamide formulation | |
CN108273064A | The pharmaceutical composition containing niacin and/or niacinamide and/or tryptophan for positive influences intestinal flora |